Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TACE plus Oncorine in unresectable HCC
NCT01869088Phase 3Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Jan 2013
- Primary completion
- Jan 2018
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Oncorine in hepatocellular carcinoma (HCC), sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
Oncorine
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT01869088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01869088.